Revenue Recognition - Drug Discovery (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Drug Discovery Services | |||
| Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |||
| Milestone payment yet to be achieved | $ 350 | $ 2,500 | |
| Revenue recognized with milestones | 0 | $ 2,171 | |
| Drug discovery contribution | |||
| Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |||
| Deferred revenue | $ 1,091 | $ 1,581 | |